 WOODCLIFF LAKE, N.J.--BUSINESS WIRE--Eagle Pharmaceuticals, Inc. Eagle or the Company Nasdaq: EGRX today announced that the Company will release its 2021 third quarter financial results on Tuesday, November 9, 2021, before the market opens. Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows: Date Tuesday, November 9, 2021 Time 8:30 a.m. ET Toll free U.S. 866-342-8591 International 203-518-9 